← Back to Analyst Consensus 
EDIT Buy
Editas Medicine, Inc.
Current Price —
Implied Upside —
Analysts 19
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Next Earnings
Nov 9, 2026 (14 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 8, 2026 | Wells Fargo | upgrade | Equal-Weight → Overweight | — | 54% |
| Sep 23, 2026 | Guggenheim | upgrade | Neutral → Buy | — | 52% |
| Aug 18, 2026 | Ladenburg Thalmann | initiate | — → Buy | — | 45% |
| May 5, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Mar 10, 2026 | Jones Trading | upgrade | Hold → Buy | — | 50% |
| Mar 9, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Sep 5, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $5 | 44% |
| Sep 3, 2025 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $4 | 54% |
| Aug 15, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $5 | 44% |
| Aug 13, 2025 | Baird | maintain | Outperform → Outperform | $6 | 55% |
| May 13, 2025 | Baird | maintain | Outperform → Outperform | $4 | 55% |
| Apr 28, 2025 | HC Wainwright & Co. | initiate | — → Buy | $3 | 44% |
| Dec 16, 2024 | Evercore ISI Group | maintain | Outperform → Outperform | $5 | 58% |
| Dec 16, 2024 | JP Morgan | downgrade | Neutral → Underweight | $0 | 54% |
| Dec 13, 2024 | RBC Capital | maintain | Sector Perform → Sector Perform | $4 | 55% |
| Dec 13, 2024 | Barclays | maintain | Equal-Weight → Equal-Weight | $3 | 53% |
| Dec 13, 2024 | Chardan Capital | downgrade | Buy → Neutral | $0 | 47% |
| Dec 13, 2024 | Baird | maintain | Outperform → Outperform | $8 | 55% |
| Dec 13, 2024 | Stifel | downgrade | Buy → Hold | $3 | 53% |
| Dec 11, 2024 | Wells Fargo | downgrade | Overweight → Equal-Weight | $4 | 54% |
| Nov 5, 2024 | Chardan Capital | maintain | Buy → Buy | $12 | 47% |
| Nov 5, 2024 | RBC Capital | maintain | Sector Perform → Sector Perform | $5 | 55% |
| Nov 5, 2024 | Stifel | maintain | Buy → Buy | $11 | 53% |
| Nov 5, 2024 | Truist Securities | maintain | Buy → Buy | $8 | 54% |
| Nov 5, 2024 | Wells Fargo | maintain | Overweight → Overweight | $7 | 54% |
| Nov 5, 2024 | Barclays | maintain | Equal-Weight → Equal-Weight | $5 | 53% |
| Oct 23, 2024 | Evercore ISI Group | maintain | In-Line → In-Line | $3 | 58% |
| Oct 23, 2024 | Wells Fargo | maintain | Overweight → Overweight | $9 | 54% |
| Oct 22, 2024 | Chardan Capital | maintain | Buy → Buy | $12 | 47% |
| Sep 19, 2024 | RBC Capital | reiterate | Sector Perform → Sector Perform | $8 | 55% |
| Sep 17, 2024 | Jones Trading | initiate | — → Buy | $13 | 50% |
| Aug 8, 2024 | Barclays | maintain | Equal-Weight → Equal-Weight | $7 | 53% |
| Aug 8, 2024 | Truist Securities | maintain | Buy → Buy | $12 | 54% |
| Aug 8, 2024 | B of A Securities | upgrade | Neutral → Buy | $15 | 53% |
| Jun 18, 2024 | Oppenheimer | maintain | Perform → Perform | $12 | 52% |
| May 30, 2024 | Evercore ISI Group | maintain | In-Line → In-Line | $7 | 58% |
| May 9, 2024 | Citigroup | maintain | Buy → Buy | $15 | 54% |
| May 9, 2024 | Morgan Stanley | upgrade | Underweight → Equal-Weight | $7 | 54% |
| May 9, 2024 | Barclays | maintain | Equal-Weight → Equal-Weight | $9 | 53% |
| Feb 29, 2024 | Citigroup | maintain | Buy → Buy | $16 | 54% |
| Feb 29, 2024 | Barclays | maintain | Equal-Weight → Equal-Weight | $11 | 53% |
| Feb 27, 2024 | JP Morgan | maintain | Neutral → Neutral | $9 | 54% |
| Dec 12, 2023 | Truist Securities | maintain | Buy → Buy | $20 | 54% |
| Oct 24, 2023 | Citigroup | upgrade | Neutral → Buy | $11 | 54% |
| Oct 18, 2023 | JP Morgan | upgrade | Underweight → Neutral | $8 | 54% |
| Oct 17, 2023 | Cantor Fitzgerald | downgrade | Overweight → Neutral | $0 | 50% |
| Sep 29, 2023 | Stifel | upgrade | Hold → Buy | $17 | 53% |
| Sep 13, 2023 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $14 | 50% |
| Aug 29, 2023 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $14 | 50% |
| Aug 3, 2023 | Oppenheimer | reiterate | Perform → Perform | $12 | 52% |
Price Target Trend
Apr 23, 2026 Latest: $6.1 Oct 25, 2026
EPS Estimates
+1y $-0.75
Lo: $-0.85 Hi: $-0.60
7 analysts ▲5
0y $-0.83
Lo: $-0.99 Hi: $-0.66
7 analysts ▲5
+1q $-0.21
Lo: $-0.28 Hi: $-0.08
7 analysts ▲5
0q $-0.21
Lo: $-0.25 Hi: $-0.19
7 analysts ▲6
Cross-Platform Signals
No cross-platform signals in the last 90 days